{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["2,4-Dioxochroman", "Acetylcholinesterase", "Alzheimer\u2019s disease", "Benzyl pyridinium", "Butyrylcholinesterase", "Docking study"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30928873", "DateCompleted": {"Year": "2020", "Month": "09", "Day": "22"}, "DateRevised": {"Year": "2020", "Month": "09", "Day": "22"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "03", "Day": "06"}], "Language": ["eng"], "ELocationID": ["10.1016/j.bioorg.2019.03.012", "S0045-2068(18)31268-9"], "Journal": {"ISSN": "1090-2120", "JournalIssue": {"Volume": "87", "PubDate": {"Year": "2019", "Month": "Jun"}}, "Title": "Bioorganic chemistry", "ISOAbbreviation": "Bioorg Chem"}, "ArticleTitle": "New benzyl pyridinium derivatives bearing 2,4-dioxochroman moiety as potent agents for treatment of Alzheimer's disease: Design, synthesis, biological evaluation, and docking study.", "Pagination": {"StartPage": "506", "EndPage": "515", "MedlinePgn": "506-515"}, "Abstract": {"AbstractText": ["A new series of benzyl pyridinium-2,4-dioxochroman derivatives 7a-o was synthesized and evaluated as new anti-Alzheimer agents. Among the synthesized compounds, the compounds 7f and 7i exhibited the most potent anti-AChE and anti-BuChE activities, respectively. The kinetic study of the compound 7f revealed that this compound inhibited AChE in a mixed-type inhibition mode. Furthermore, the docking study of the compounds 7f and 7i showed that these compounds bound to both the catalytic site (CS) and peripheral anionic site (PAS) of AChE and BuChE, respectively. The compound 7f also exhibited a greater self-induced A\u03b2 peptide aggregation inhibitory activity in compare to donepezil. Furthermore, the neuroprotective activity of this compound at 20\u202f\u03bcM was comparable to that of the standard neuroprotective agent (quercetin)."], "CopyrightInformation": "Copyright \u00a9 2019 Elsevier Inc. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chemistry, College of Science, University of Tehran, Tehran, Iran."}], "LastName": "Mollazadeh", "ForeName": "Marjan", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran."}], "LastName": "Mohammadi-Khanaposhtani", "ForeName": "Maryam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chemistry, College of Science, University of Tehran, Tehran, Iran. Electronic address: zonouzi@khayam.ut.ac.ir."}], "LastName": "Zonouzi", "ForeName": "Afsaneh", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran."}], "LastName": "Nadri", "ForeName": "Hamid", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran; Medicinal Plants and Natural Products Research Center, Hamadan University of Medical Sciences, Hamadan, Iran."}], "LastName": "Najafi", "ForeName": "Zahra", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Larijani", "ForeName": "Bagher", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: momahdavi@tums.ac.ir."}], "LastName": "Mahdavi", "ForeName": "Mohammad", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Bioorg Chem", "NlmUniqueID": "1303703", "ISSNLinking": "0045-2068"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Amyloid beta-Peptides"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzyl Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Cholinesterase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Chromans"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Pyridinium Compounds"}, {"RegistryNumber": "BBX060AN9V", "NameOfSubstance": "Hydrogen Peroxide"}, {"RegistryNumber": "EC 3.1.1.7", "NameOfSubstance": "Acetylcholinesterase"}, {"RegistryNumber": "EC 3.1.1.8", "NameOfSubstance": "Butyrylcholinesterase"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "Acetylcholinesterase"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Amyloid beta-Peptides"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Benzyl Compounds"}, {"QualifierName": ["metabolism"], "DescriptorName": "Butyrylcholinesterase"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Death"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Cholinesterase Inhibitors"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Chromans"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Drug Design"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["antagonists & inhibitors", "pharmacology"], "DescriptorName": "Hydrogen Peroxide"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": [], "DescriptorName": "PC12 Cells"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Pyridinium Compounds"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2018", "Month": "11", "Day": "5"}, {"Year": "2019", "Month": "3", "Day": "4"}, {"Year": "2019", "Month": "3", "Day": "5"}, {"Year": "2019", "Month": "4", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "4", "Day": "1", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30928873", "10.1016/j.bioorg.2019.03.012", "S0045-2068(18)31268-9"]}}]}